Wellington Management Group’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.53M Buy
695,728
+29,161
+4% +$106K ﹤0.01% 1516
2025
Q1
$1.28M Buy
666,567
+164,440
+33% +$316K ﹤0.01% 1645
2024
Q4
$954K Buy
502,127
+97,409
+24% +$185K ﹤0.01% 1711
2024
Q3
$534K Buy
+404,718
New +$534K ﹤0.01% 1792
2022
Q2
Sell
-316,863
Closed -$227K 2064
2022
Q1
$227K Buy
316,863
+2,801
+0.9% +$2.01K ﹤0.01% 2061
2021
Q4
$710K Buy
+314,062
New +$710K ﹤0.01% 1872
2021
Q3
Sell
-10,736,859
Closed -$40.7M 2143
2021
Q2
$40.7M Sell
10,736,859
-101,306
-0.9% -$384K 0.01% 887
2021
Q1
$36.7M Sell
10,838,165
-1,752,298
-14% -$5.93M 0.01% 901
2020
Q4
$35.3M Buy
12,590,463
+4,665,491
+59% +$13.1M 0.01% 875
2020
Q3
$19.9M Buy
7,924,972
+650,249
+9% +$1.63M ﹤0.01% 952
2020
Q2
$98.8M Buy
7,274,723
+5,549,182
+322% +$75.4M 0.02% 526
2020
Q1
$13.1M Buy
1,725,541
+828,814
+92% +$6.28M ﹤0.01% 978
2019
Q4
$5.67M Buy
896,727
+496,434
+124% +$3.14M ﹤0.01% 1305
2019
Q3
$1.57M Sell
400,293
-10,065
-2% -$39.5K ﹤0.01% 1642
2019
Q2
$1.99M Sell
410,358
-69
-0% -$334 ﹤0.01% 1629
2019
Q1
$3.36M Buy
410,427
+519
+0.1% +$4.25K ﹤0.01% 1480
2018
Q4
$2.27M Buy
409,908
+75
+0% +$415 ﹤0.01% 1608
2018
Q3
$3.62M Sell
409,833
-156,024
-28% -$1.38M ﹤0.01% 1558
2018
Q2
$5.65M Sell
565,857
-77,227
-12% -$771K ﹤0.01% 1455
2018
Q1
$6.13M Buy
643,084
+266,158
+71% +$2.54M ﹤0.01% 1417
2017
Q4
$5.61M Buy
376,926
+63,945
+20% +$951K ﹤0.01% 1441
2017
Q3
$6.16M Buy
312,981
+122,545
+64% +$2.41M ﹤0.01% 1412
2017
Q2
$2.74M Buy
190,436
+38,416
+25% +$552K ﹤0.01% 1611
2017
Q1
$1.4M Buy
152,020
+22,520
+17% +$207K ﹤0.01% 1828
2016
Q4
$1.35M Sell
129,500
-13,830
-10% -$144K ﹤0.01% 1791
2016
Q3
$1.3M Hold
143,330
﹤0.01% 1771
2016
Q2
$1.07M Sell
143,330
-2,070
-1% -$15.5K ﹤0.01% 1756
2016
Q1
$1.31M Buy
+145,400
New +$1.31M ﹤0.01% 1715